Systemic Lupus Erythematosus

• GSK Investigational Site — Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
• GSK Investigational Site — Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
• GSK Investigational Site — La Plata, Buenos Aires, Argentina
• GSK Investigational Site — Rosario, Santa Fe Province, Argentina

• Duke University Medical Center — Durham, North Carolina, United States

• GSK Investigational Site — Hefei, Anhui, China
• GSK Investigational Site — Guangzhou, Guangdong, China
• GSK Investigational Site — Guangzhou, Guangdong, China
• GSK Investigational Site — Guangzhou, Guangdong, China

• Ethics Committee of Renji Hospital, Shanghai Jiaotong University School of Medicine — Shanghai, Shanghai Municipality, China

• AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM. — Paris, France
• Rhumatology department, CHU Strasbourg, Hautepierre hospital — Strasbourg, France

• Department of Medicine, Tuen Mun Hospital — Hong Kong, China

Not specified

• UC San Diego — La Jolla, California, United States
• Loma Linda University — Loma Linda, California, United States
• East Bay Rheumatology Medical Group — San Leandro, California, United States
• Yale University School of Medicine — New Haven, Connecticut, United States

• CMAX Clinical Research — Adelaide, South Australia, Australia

• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Scottsdale, Arizona, United States
• GSK Investigational Site — Tucson, Arizona, United States
• GSK Investigational Site — La Jolla, California, United States